Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2947764
Reference Type
Journal Article
Subtype
Review
Title
Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water
Author(s)
Moffat, I; Chepelev, NL; Labib, S; Bourdon-Lacombe, J; Kuo, B; Buick, JK; Lemieux, F; Williams, A; Halappanavar, S; Malik, AI; Luijten, M; Aubrecht, J; Hyduke, DR; Fornace, AJ; Swartz, CD; Recio, L; Yauk, CL
Year
2015
Is Peer Reviewed?
Yes
Journal
Critical Reviews in Toxicology
ISSN:
1040-8444
EISSN:
1547-6898
Publisher
TAYLOR & FRANCIS LTD
Location
ABINGDON
Volume
45
Issue
1
Page Numbers
1-43
Language
English
PMID
25605026
DOI
10.3109/10408444.2014.973934
Web of Science Id
WOS:000348199100001
URL
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921459862&doi=10.3109%2f10408444.2014.973934&partnerID=40&md5=24415391eac738bb3c65395d946d11f7
Exit
Abstract
Toxicogenomics is proposed to be a useful tool in human health risk assessment. However, a systematic comparison of traditional risk assessment approaches with those applying toxicogenomics has never been done. We conducted a case study to evaluate the utility of toxicogenomics in the risk assessment of benzo[a]pyrene (BaP), a well-studied carcinogen, for drinking water exposures. Our study was intended to compare methodologies, not to evaluate drinking water safety. We compared traditional (RA1), genomics-informed (RA2) and genomics-only (RA3) approaches. RA2 and RA3 applied toxicogenomics data from human cell cultures and mice exposed to BaP to determine if these data could provide insight into BaP's mode of action (MOA) and derive tissue-specific points of departure (POD). Our global gene expression analysis supported that BaP is genotoxic in mice and allowed the development of a detailed MOA. Toxicogenomics analysis in human lymphoblastoid TK6 cells demonstrated a high degree of consistency in perturbed pathways with animal tissues. Quantitatively, the PODs for traditional and transcriptional approaches were similar (liver 1.2 vs. 1.0 mg/kg-bw/day; lungs 0.8 vs. 3.7 mg/kg-bw/day; forestomach 0.5 vs. 7.4 mg/kg-bw/day). RA3, which applied toxicogenomics in the absence of apical toxicology data, demonstrates that this approach provides useful information in data-poor situations. Overall, our study supports the use of toxicogenomics as a relatively fast and cost-effective tool for hazard identification, preliminary evaluation of potential carcinogens, and carcinogenic potency, in addition to identifying current limitations and practical questions for future work.
Keywords
benchmark dose; carcinogens; dose-response; environmental pollutant; genomics; human health risk assessment; mode of action; point of departure; polycyclic aromatic hydrocarbon; transcriptomics
Tags
IRIS
•
Ammonia, Oral - Problem Formulation
•
Benzo(a)pyrene (BaP)
Identified During External Peer Review
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity